Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBSXBoston Scientific
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Bullish
| Metric | BSX | TMO |
|---|
| Close | 43.91 | 648.43 |
| Market Cap | $63.6B | $240B |
| 1M | −14.62% | +10.75% |
| P/E (TTM) | 17.3 | 34.4 |
| Forward P/E | 13.4 | 21.8 |
| P/E 5-Yr Percentile | 0 | 65 |
| P/S | 3.0 | 5.2 |
| P/B | 2.6 | 4.6 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $5.4B | $12.0B |
| Revenue YoY | +7.5% | +10.5% |
| Gross Margin | 70.7% | — |
| Latest Quarter EPS | 0.61 | 4.68 |
| Avg Post-Earnings Move | ±1.5% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | — | 2.36% |
| 90-Day Net Insider Buying | +$9.5M | −$38.9M |
BSX · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
